Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Adapthealth stock
Learn how to easily invest in Adapthealth stock.
Adapthealth Corp is a medical devices business based in the US. Adapthealth shares (AHCO) are listed on the NASDAQ and all prices are listed in US Dollars. Adapthealth employs 10,700 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Adapthealth
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AHCO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Adapthealth stock price (NASDAQ: AHCO)Use our graph to track the performance of AHCO stocks over time.
Adapthealth shares at a glance
|Latest market close||$18.17|
|52-week range||$11.40 - $28.75|
|50-day moving average||$16.38|
|200-day moving average||$19.51|
|Wall St. target price||$24.10|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.81|
Buy Adapthealth shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Adapthealth stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Adapthealth price performance over time
|1 week (2022-06-27)||-5.71%|
|1 month (2022-06-02)||-0.06%|
|3 months (2022-03-31)||N/A|
|6 months (2022-01-04)||-21.98%|
|1 year (2021-07-02)||-33.81%|
|2 years (2020-07-02)||-9.15%|
|3 years (2019-07-03)||80.08%|
|5 years (2017-06-30)||N/A|
Is Adapthealth stock undervalued or overvalued?
Valuing Adapthealth stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Adapthealth's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Adapthealth's P/E ratio
Adapthealth's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, Adapthealth shares trade at around 22x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Adapthealth's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $573.3 million.
The EBITDA is a measure of a Adapthealth's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.7 billion|
|Operating margin TTM||10.61%|
|Gross profit TTM||$528 million|
|Return on assets TTM||3.67%|
|Return on equity TTM||10.43%|
|Market capitalisation||$2.4 billion|
TTM: trailing 12 months
Adapthealth share dividends
We're not expecting Adapthealth to pay a dividend over the next 12 months.
Adapthealth share price volatility
Over the last 12 months, Adapthealth's shares have ranged in value from as little as $11.4 up to $28.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adapthealth's is 0.5714. This would suggest that Adapthealth's shares are less volatile than average (for this exchange).
AdaptHealth Corp. , together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania. .
Adapthealth in the news
Should You Be Concerned About AdaptHealth Corp.'s (NASDAQ:AHCO) ROE?
Frequently asked questionsWhat percentage of Adapthealth is owned by insiders or institutions?
Currently 24.961% of Adapthealth shares are held by insiders and 80.652% by institutions. How many people work for Adapthealth?
Latest data suggests 10,700 work at Adapthealth. When does the fiscal year end for Adapthealth?
Adapthealth's fiscal year ends in December. Where is Adapthealth based?
Adapthealth's address is: 220 West Germantown Pike, Plymouth Meeting, PA, United States, 19462 What is Adapthealth's ISIN number?
Adapthealth's international securities identification number is: US00653Q1022 What is Adapthealth's CUSIP number?
Adapthealth's Committee on Uniform Securities Identification Procedures number is: 00653Q102
More guides on Finder
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert